EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A cell-impermeable kinase inhibitor uncovers outside-in signaling pathways that promote HIV-1 infection

Kelsey Vinzant iD, Natalia Cheshenko, Heng Pan, Ronald Cutler, Joshua N Buckler iD, Andreas Luxenburger, Lawrence D Harris iD, Jeffrey R Johnson iD, Steven C Almo, Betsy C Herold iD

Journal of Virology · 23.06.2026 · 100 (6)

DOI: 10.1128/jvi.00160-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 23.06.2026. Verfasst von Kelsey Vinzant und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology-Immunology, Albert Einstein College of Medicine, Bronx, New York, USA. Hauptthemen laut MEDLINE: HIV-1, Signal Transduction, HIV Infections, Virus Internalization. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Studies of herpes simplex virus (HSV) entry revealed a previously unrecognized “outside-in” signaling pathway involving phosphatidylserine (PS) scrambling and associated translocation and subsequent extracellular activation of canonical intracellular proteins, including Akt. We hypothesized that HIV-1, which activates a different scramblase, TMEM16F, to induce PS externalization, may similarly trigger an “outside-in” signaling response to promote viral entry. To study this process, we utilized a cell-impermeable staurosporine analog, alkyl-CIMSS, which is a broadly active kinase inhibitor that blocks HSV-induced exofacial Akt phosphorylation, and HSV entry. We show that TMEM16F-mediated PS externalization in response to HIV is not associated with Akt translocation; however, surprisingly, pretreatment of cells with alkyl-CIMSS enhanced HIV-1 infection post-entry. To identify potential biological processes that mediated this enhancement, we performed whole-cell total and phosphoproteomics, and bulk RNA sequencing. Cells treated with alkyl-CIMSS exhibited increased cyclin-dependent kinase (CDK) activity, resulting in higher levels of phosphorylated SAMHD1. Further, alkyl-CIMSS treatment robustly upregulated the cell surface density of the proteoglycan glypican-1 (GPC1). Lentivirus-driven GPC1 overexpression or shRNA knockdown demonstrated that, independent of alkyl-CIMSS treatment, GPC1 expression promotes HIV infection. Collectively, these findings demonstrate that alkyl-CIMSS modulates the exofacial plasma membrane to promote susceptibility to HIV infection by increasing CDK activity and upregulating GPC1. IMPORTANCE The cell-impermeable pan-kinase inhibitor alkyl-CIMSS inhibits HSV infection by blocking phosphorylation of exofacial Akt. In contrast, alkyl-CIMSS enhances HIV infection. This increase was associated with enhanced cyclin-dependent kinase activity and upregulation of surface-presented glypican-1. These results illustrate that distinct processes associated with the exofacial proteome can either promote viral infection, as observed for HIV, or impede infection, as in the case of HSV, and may facilitate the identification of pathways that can be targeted for future antiviral drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1Signal TransductionHIV InfectionsVirus InternalizationProtein Kinase InhibitorsStaurosporineHumansPhosphorylationProto-Oncogene Proteins c-aktSAM Domain and HD Domain-Containing Protein 1Phosphatidylserines

Stichwörter der Autor:innen

HIV-1T cellsTMEM16Fglypican-1kinase inhibitor

Substanzen

Protein Kinase InhibitorsStaurosporineProto-Oncogene Proteins c-aktSAM Domain and HD Domain-Containing Protein 1PhosphatidylserinesSAMHD1 protein, human

Autor:innen und Institutionen

  • Department of Microbiology-Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Genetics, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA.

ORCID-Profile: Kelsey Vinzant, Joshua N Buckler, Lawrence D Harris, Jeffrey R Johnson, Betsy C Herold

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Vinzant, K., Cheshenko, N., Pan, H., Cutler, R., Buckler, J. N., Luxenburger, A., Harris, L. D., Johnson, J. R., Almo, S. C., & Herold, B. C. (2026). A cell-impermeable kinase inhibitor uncovers outside-in signaling pathways that promote HIV-1 infection. Journal of Virology, 100(6). https://doi.org/10.1128/jvi.00160-26

Vancouver

Vinzant K, Cheshenko N, Pan H, Cutler R, Buckler JN, Luxenburger A, et al. A cell-impermeable kinase inhibitor uncovers outside-in signaling pathways that promote HIV-1 infection. Journal of Virology. 2026;100(6). doi:10.1128/jvi.00160-26

BibTeX
@article{Vinzant2026,
  author = {Vinzant, Kelsey and Cheshenko, Natalia and Pan, Heng and Cutler, Ronald and Buckler, Joshua N and Luxenburger, Andreas and Harris, Lawrence D and Johnson, Jeffrey R and Almo, Steven C and Herold, Betsy C},
  title = {A cell-impermeable kinase inhibitor uncovers outside-in signaling pathways that promote HIV-1 infection},
  journal = {Journal of Virology},
  year = {2026},
  volume = {100},
  number = {6},
  doi = {10.1128/jvi.00160-26}
}
Kostenlos starten →